摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tributyl(2,6-difluorophenyl)stannane

中文名称
——
中文别名
——
英文名称
tributyl(2,6-difluorophenyl)stannane
英文别名
(2,6-difluorophenyl)tributyltin;2,6-Difluorophenyltributyltin;tributyl-(2,6-difluorophenyl)stannane
tributyl(2,6-difluorophenyl)stannane化学式
CAS
——
化学式
C18H30F2Sn
mdl
——
分子量
403.143
InChiKey
DLTHSKKNYFFRAQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.02
  • 重原子数:
    21
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    tributyl(2,6-difluorophenyl)stannane四(三苯基膦)钯一水合肼 作用下, 以 甲醇 、 xylene 为溶剂, 反应 24.0h, 生成 5-(2,6-difluorophenyl)nicotinoyl hydrazide
    参考文献:
    名称:
    Biarylcarbamoylindolines Are Novel and Selective 5-HT2C Receptor Inverse Agonists:  Identification of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a Potential Antidepressant/Anxiolytic Agent
    摘要:
    The evolution, synthesis, and biological activity of a novel series of 5-HT2C receptor inverse agonists are reported. Biarylcarbamoylindolines have been identified with excellent 5-HT2C affinity and selectivity over 5-HT2A receptors. In addition, (pyridyloxypyridyl)carbamoylindolines have been discovered with additional selectivity over the closely related 5-HT2B receptor. Compounds from this series are inverse agonists at the human cloned 5-HT2C receptor, completely abolishing basal activity in a functional assay. The new series have reduced P450 inhibitory liability compared to a previously described series of 1-(3-pyridylcarbamoyl)indolines (Bromidge et al. J. Med. Chem. 1998, 41, 1598) from which they evolved. Compounds from this series showed excellent oral activity in a rat mCPP hypolocomotion model and in animal models of anxiety. On the basis of their favorable biological profile, 32 (SB-228357) and 40 (SB-243213) have been selected for further evaluation to determine their therapeutic potential for the treatment of CNS disorders such as depression and anxiety.
    DOI:
    10.1021/jm990388c
  • 作为产物:
    描述:
    1,3-二氟苯三丁基氯化锡正丁基锂 作用下, 以 四氢呋喃正己烷 为溶剂, 反应 4.0h, 以88.6%的产率得到tributyl(2,6-difluorophenyl)stannane
    参考文献:
    名称:
    用于制备 2,6-双(二苯基膦)溴苯和相关双(氧化膦)的有机锡路线。新型配体的前体
    摘要:
    2,6-二氟苯基三烷基锡烷2,6-F 2 C 6 H 3 SnR 3 ( 1,R=Me;2,R=Bu)由商业产品制备。使用Ph 2 PLi,1和2进行亲核取代得到2,6-双(二苯基膦基)苯基三烷基锡烷2,6-(Ph 2 P) 2 C 6 H 3 SnR 3 ( 3 , R=Me; 4 , R=卜)。的反应3与Ñ正丁基锂和BRCH 2 CH 2Br得到2,6-双(二苯基膦基)溴苯(2,6-(Ph 2 P) 2 C 6 H 3 Br, 5 ),其氧化得到相关的双(氧化膦) 2,6-[Ph 2 P(O)] 2 C 6 H 3 Br ( 6 )。5与n- BuLi反应生成 2,6-双(二苯基膦基)苯基锂、2,6-(Ph 2 P) 2 C 6 H 3 Li ( 7 )。尝试制备相关的双(氧化膦)2,6-[Ph 2 P(O)] 2来自6 的C 6 H 3 Li ( 8 )在低温下以类似的方式受到分解的
    DOI:
    10.1002/zaac.202100210
点击查看最新优质反应信息

文献信息

  • Pyranodipyridine Compound
    申请人:Eisai R&D Management Co., Ltd.
    公开号:US20170137436A1
    公开(公告)日:2017-05-18
    Compounds represented by formulae (I) to (XXII) or pharmaceutically acceptable salts thereof:
    由化学式(I)到(XXII)表示的化合物或其药用可接受的盐:
  • Copper-catalyzed arylstannylation of arynes in a sequence
    作者:Hideya Tanaka、Hitoshi Kuriki、Teruhiko Kubo、Itaru Osaka、Hiroto Yoshida
    DOI:10.1039/c9cc02738f
    日期:——
    Copper-catalyzed arylstannylation of arynes has been developed. This transformation enables variously substituted ortho-stannylbiaryls and teraryls to be constructed straightforwardly. An electron-deficient tin center is the key, and thus the single or dual insertion of arynes into arylstannanes is precisely controllable by simply changing the equivalence of aryne precursors.
    已经开发了铜催化的芳烃的芳基甲锡烷基化。该转化使得可以直接构建各种取代的邻-锡烷基二芳基和三芳基。缺电子的锡中心是关键,因此,只需简单地改变芳烃前体的当量,即可精确控制芳烃单芳基或双芳烃的插入。
  • Catalytic C−H Bond Stannylation: A New Regioselective Pathway to C−Sn Bonds via C−H Bond Functionalization
    作者:Meghan E. Doster、Jillian A. Hatnean、Tamara Jeftic、Sunjay Modi、Samuel A. Johnson
    DOI:10.1021/ja105588v
    日期:2010.9.1
    ubiquitous Stille coupling reaction utilizes Sn-C bonds and is of great utility to organic chemists. Unlike the B-C bonds used in the Miyaura-Suzuki coupling reaction, which are readily obtained via direct borylation of C-H bonds, routes to organotin compounds via direct C-H bond functionalization are lacking. Here we report that the nickel-catalyzed reaction of fluorinated arenes and pyridines with vinyl
    无处不在的 Stille 偶联反应利用 Sn-C 键,对有机化学家非常有用。与 Miyaura-Suzuki 偶联反应中使用的 BC 键不同,BC 键很容易通过 CH 键的直接硼酸化获得,但缺乏通过直接 CH 键官能化获得有机锡化合物的途径。在这里,我们报告氟化芳烃和吡啶与乙烯基锡烷的镍催化反应没有通过 CF 活化提供预期的乙烯基化合物,而是通过 CH 官能化提供新的 Sn-C 键,同时失去乙烯。这种机制为将 CH 键直接转化为碳-杂原子键提供了一种新的出乎意料的方法。
  • An Organotin Route for the Preparation of 2,6‐Bis(diphenylphosphino)bromo‐benzene and the Related Bis(Phosphine Oxide). Precursors for Novel Ligands
    作者:Fabio Meyer、Thomas Kuzmera、Enno Lork、Matthias Vogt、Jens Beckmann
    DOI:10.1002/zaac.202100210
    日期:2021.10.12
    R=Bu) were prepared from commercial products. With Ph2PLi, 1 and 2 underwent nucleophilic substitution to give the 2,6-bis(diphenylphosphino)phenyltrialkylstannanes 2,6-(Ph2P)2C6H3SnR3 (3, R=Me; 4, R=Bu). The reaction of 3 with n-BuLi and BrCH2CH2Br afforded 2,6-bis(diphenylphosphino)bromobenzene (2,6-(Ph2P)2C6H3Br, 5), the oxidation of which gave the related bis(phosphine oxide) 2,6-[Ph2P(O)]2C6H3Br
    2,6-二氟苯基三烷基锡烷2,6-F 2 C 6 H 3 SnR 3 ( 1,R=Me;2,R=Bu)由商业产品制备。使用Ph 2 PLi,1和2进行亲核取代得到2,6-双(二苯基膦基)苯基三烷基锡烷2,6-(Ph 2 P) 2 C 6 H 3 SnR 3 ( 3 , R=Me; 4 , R=卜)。的反应3与Ñ正丁基锂和BRCH 2 CH 2Br得到2,6-双(二苯基膦基)溴苯(2,6-(Ph 2 P) 2 C 6 H 3 Br, 5 ),其氧化得到相关的双(氧化膦) 2,6-[Ph 2 P(O)] 2 C 6 H 3 Br ( 6 )。5与n- BuLi反应生成 2,6-双(二苯基膦基)苯基锂、2,6-(Ph 2 P) 2 C 6 H 3 Li ( 7 )。尝试制备相关的双(氧化膦)2,6-[Ph 2 P(O)] 2来自6 的C 6 H 3 Li ( 8 )在低温下以类似的方式受到分解的
  • Tetracyclic compound
    申请人:Kyowa Hakko Kogyo Co., Ltd.
    公开号:US05646283A1
    公开(公告)日:1997-07-08
    This invention relates to a novel tetracyclic compound represented by formula (I): ##STR1## or its pharmacologically-acceptable salt. The compound of this invention has strong immunosuppressive activity, and is useful as an immunosuppressive agent and as an agent for treating autoimmune disease.
    本发明涉及一种新型四环化合物,其化学式为(I): ##STR1## 或其药学上可接受的盐。该化合物具有强烈的免疫抑制活性,可作为免疫抑制剂和治疗自身免疫性疾病的药物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐